Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.
about
Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension24-h Efficacy of Glaucoma Treatment OptionsThe effect on intraocular pressure of latanoprost once or four times dailyEffects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeabilityUse of latanoprost to reduce acute intraocular pressure rise following neodymium: Yag laser iridotomy.Latanoprost versus combined therapy with timolol plus dorzolamide: IOP-lowering effect in open-angle glaucoma.Neuroprotective effect of latanoprost on rat retinal ganglion cells.Glaucoma: a review of adjunctive therapy and new management strategies.Performing meta-analysis with incomplete statistical information in clinical trialsFirst-line latanoprost therapy in ocular hypertension or open-angle glaucoma patients: a 3-month efficacy analysis stratified by initial intraocular pressureContralateral intraocular pressure lowering effect of prostaglandin analoguesIncidence, severity and factors related to drug-induced keratoepitheliopathy with glaucoma medications.Ocular lubricant use in medically and surgically treated glaucoma: a retrospective longitudinal analysis.Comparative efficacy and safety of the fixed versus unfixed combination of latanoprost and timolol in Chinese patients with open-angle glaucoma or ocular hypertension.Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertensionThe influence of topical prostaglandin analogues in inflammation after selective laser trabeculoplasty treatment.A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertensionRole of PKCepsilon in PGF2alpha-stimulated MMP-2 secretion from human ciliary muscle cells.Randomized trial comparing three fixed combinations of prostaglandins/prostamide with timolol maleate.Clinical options for the reduction of elevated intraocular pressureFixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure.A double masked comparison of the intraocular pressure reducing effect of latanoprost 0.005% and 0.001% administered once daily in open angle glaucoma and ocular hypertension.Effects on IOP restoration and blood-aqueous barrier after long-term treatment with latanoprost in open angle glaucoma and ocular hypertension.Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish LaA comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension: a 3 month, randomised study. Ireland Latanoprost Study Group.Additive effect of unoprostone and latanoprost in patients with elevated intraocular pressure.Incidence of iris colour change in latanoprost treated eyes.Unoprostone as adjunctive therapy to timolol: a double masked randomised study versus brimonidine and dorzolamideA 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertensionShort term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies.Persistency and treatment failure in newly diagnosed open angle glaucoma patients in the United KingdomPatterns of opioid analgesic prescription among patients with osteoarthritis.Intraocular pressure after replacement of current dual therapy with latanoprost monotherapy in patients with open angle glaucoma.In Vivo Effects of Preservative-free and Preserved Prostaglandin Analogs: Mouse Ocular Surface Study.Medical management of angle closure glaucoma.Bimatoprost versus latanoprost in lowering intraocular pressure in glaucoma and ocular hypertension: results from parallel-group comparison trials.Resting pulse rates in a glaucoma clinic: the effect of topical and systemic beta-blocker usage.Intraocular Pressure-Lowering Effect of Latanoprost Is Hampered by Defective Cervical Lymphatic Drainage.Topical treatment of glaucoma: established and emerging pharmacology.Prostanoids in the therapy of glaucoma.
P2860
Q24672885-7D56F0DC-F38C-4547-97CB-76F4D69BB0A9Q26766594-A182F8C4-32E6-42A1-8099-C1540A42FA34Q28360261-35784E6F-3653-4A23-B45A-67ABA0C76340Q28379588-3B17FBCD-10A0-43FD-A4DF-D372DCF65BCDQ31075828-C0CD57D9-BFAB-4516-A927-68EA81430848Q31890726-88296E20-3D69-460D-89FA-E942015F897CQ33231566-DB7B66FE-F4A2-4BC4-97E7-7ED2724E7A1FQ33307040-74BB7E42-132A-46F5-B028-660C721CFD96Q33360471-431E9CD2-EEFD-40AA-93D3-84BCE3638C40Q33534044-66ECA4C3-0A58-4D84-B1B4-F28DF6CA1B16Q33785986-2134011F-EB96-41E2-96CE-2C47B0656066Q33819802-92F5004C-650D-490D-9280-833661CE7703Q33865232-39BC3A42-26A4-4A88-8709-F66EE599A6D4Q33996251-44B613DE-E97D-4C8F-937D-EBFCD378CCE6Q34043309-E5D9977A-A4C5-47C3-BF73-C4FCADDA6B6AQ34075906-29137E85-ED60-4239-85B4-B1DFDDCB9F6EQ34274254-C6E72610-245B-4B37-B07A-ECB289A2525DQ34309970-6E7FAF02-6021-4606-9D54-6CFB4A02D752Q34606706-4071B289-2BCD-4EA1-AC2D-3494D073C0F7Q34708267-F8EDBA9C-CA18-4E53-AF82-C0F038A01087Q34996623-3086830C-EC1C-475C-9B22-228D861621C8Q35298399-3FCF7055-0FCB-4821-89EB-EBFF6975E442Q35300174-8CEAEF2F-C10A-49D4-8F70-A6E60B0ADB3DQ35313371-C2CBA91D-9A6F-43E8-905F-6CB66CE58984Q35314724-AA2BAF9B-BE9E-42E2-99E0-CA4D47DF08CAQ35589367-0A2AE04B-5CDF-4846-BD82-4AA556F385E5Q35590132-40355148-1875-42CD-B75C-1AA90A8CBFFBQ35590963-330B11AD-F945-4061-B9CC-EC31890711F1Q35591747-DF28D163-77A9-4CC9-9655-0AB1C0E8BA55Q35592524-39596BAF-1FF3-4920-9738-3D1ACB7491EEQ35592544-1FC9B0C2-A2C9-4D2F-8224-789610BC0443Q35775628-09B84844-1C15-4300-90F1-BCC786A11BC4Q35894656-77DF4D31-5CA7-4DF4-829D-F8FAB2DAE764Q35904919-8B30F913-4AB7-478F-85C5-C7F3BDE2ACDFQ35932526-B6A115A4-E3E8-409C-8A1E-7F5717029C6CQ35987460-2DC5F620-F922-4360-B46E-7E7F0638E047Q36085655-11A142F0-835C-4E74-97A8-A208E0C52C9EQ36247598-08F1DE4B-D3FC-44C9-A261-5AF7D997F7EDQ36365495-FF342408-EE56-4079-91B9-827439B432F0Q36580774-2253BBA3-FD6A-4142-BA12-2C1668959B53
P2860
Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Effects on intraocular pressur ...... avian Latanoprost Study Group.
@en
Effects on intraocular pressur ...... avian Latanoprost Study Group.
@nl
type
label
Effects on intraocular pressur ...... avian Latanoprost Study Group.
@en
Effects on intraocular pressur ...... avian Latanoprost Study Group.
@nl
prefLabel
Effects on intraocular pressur ...... avian Latanoprost Study Group.
@en
Effects on intraocular pressur ...... avian Latanoprost Study Group.
@nl
P1433
P1476
Effects on intraocular pressur ...... avian Latanoprost Study Group.
@en
P2093
Stjernschantz J
P304
P356
10.1016/S0161-6420(95)30798-1
P577
1995-12-01T00:00:00Z